Breakdown of prescribed CVD medications in the Kenyatta National Hospital cohort.
收藏NIAID Data Ecosystem2026-03-14 收录
数据链接：
官方服务：
资源简介：
Breakdown of prescribed CVD medications in the Kenyatta National Hospital cohort.
应用场景：
创建时间：
2023-01-20
相关数据集
Supplementary Material for: Prescription Rates of Cardiovascular Medications in a Large UK Primary Care Chronic Kidney Disease Cohort
Background and Aims: Chronic kidney disease (CKD) is associated with increased cardiovascular (CV) risk. Guidelines have suggested the universal use of statins in CKD but aspirin's role
DataCite Commons2020-09-02 更新70
sj-xlsx-1-tak-10.1177_17539447221137170 – Supplemental material for Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England’s prescription data during the COVID-19 pandemic (January 2019 to October 2020)
Supplemental material, sj-xlsx-1-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England’s prescription data d
DataCite Commons2024-08-28 更新60
Risk ratios (RRs) and 95% confidence intervals for filling a prescription for carvedilol, bisoprolol, or sustained-release metoprolol succinate after discharge from a hospitalization for heart failure with reduced ejection fraction (HFrEF).
Risk ratios (RRs) and 95% confidence intervals for filling a prescription for carvedilol, bisoprolol, or sustained-release metoprolol succinate after discharge from a hospitalization for heart failure
NIAID Data Ecosystem20
sj-xlsx-3-tak-10.1177_17539447221137170 – Supplemental material for Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England’s prescription data during the COVID-19 pandemic (January 2019 to October 2020)
Supplemental material, sj-xlsx-3-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England’s prescription data d
DataCite Commons2024-08-28 更新60
sj-xlsx-2-tak-10.1177_17539447221137170 – Supplemental material for Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England’s prescription data during the COVID-19 pandemic (January 2019 to October 2020)
Supplemental material, sj-xlsx-2-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England’s prescription data d
DataCite Commons2024-08-28 更新30
